number of downloads : ?
language
eng
Author
Hayashi Mitsuhiro Division of Molecular Pharmacology, National Cancer Center Research Institute, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
Aikawa Hiroaki Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
Ohuchi Mayu Division of Molecular Pharmacology, National Cancer Center Research Institute, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
Tamura Kenji Department of Breast and Medical Oncology, National Cancer Center Hospital, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
Fujiwara Yasuhiro Department of Breast and Medical Oncology, National Cancer Center Hospital, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
Hamada Akinobu Division of Molecular Pharmacology, National Cancer Center Research Institute, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
Journal Title
SCIENTIFIC REPORTS
Volume
7
ISSN
2045-2322
Published Date
2017-10-3
DOI
PubMed ID
Publisher
NATURE PUBLISHING GROUP
NII Type
Journal Article
OAI-PMH Set
Faculty of Medicine
Remark
We thank all the people related to this study including patient and family. We also thank N. Ohtsuka, S. Ryu, T. Yoshino, Y. Murai, M. Mizui, M. Nishidate, and R. Matsukane for their help. This work was supported by grants from the Accelerating Regulatory Science Initiative, Ministry of Health, Labour and Welfare, Japan (Y.F.), the National Cancer Center Development Fund (26-A-20, A.H.), and in part the Project for Cancer Research And Therapeutic Evolution, Japan Agency for Medical Research and Development (16cm0106223h0001, M.H.).